{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T19:55:21Z","timestamp":1769802921247,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271821"],"award-info":[{"award-number":["82271821"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10067-025-07854-6","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T01:58:27Z","timestamp":1765850307000},"page":"731-743","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Single high-dose intramuscular injection versus short-term low-dose oral glucocorticoids as bridging therapy in active rheumatoid arthritis: a retrospective cohort study on remission induction"],"prefix":"10.1007","volume":"45","author":[{"given":"Haiye","family":"Ren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nana","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinzhu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jialin","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junna","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutong","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiongyi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfen","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huihui","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuochao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinchao","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengde","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3858-0373","authenticated-orcid":false,"given":"Hong-Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"issue":"9746","key":"7854_CR1","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","volume":"376","author":"DL Scott","year":"2010","unstructured":"Scott DL, Wolfe F, Huizinga TW (2010) Rheumatoid arthritis. Lancet 376(9746):1094\u20131108. https:\/\/doi.org\/10.1016\/S0140-6736(10)60826-4","journal-title":"Lancet"},{"key":"7854_CR2","doi-asserted-by":"publisher","unstructured":"Smolen JS, Landew\u00e9 RBM, Bergstra SA, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update [published correction appears in Ann Rheum Dis. 2023 Mar;82(3):e76. https:\/\/doi.org\/10.1136\/ard-2022-223356corr1.]. Ann Rheum Dis. 2023;82(1):3\u201318. https:\/\/doi.org\/10.1136\/ard-2022-223356","DOI":"10.1136\/ard-2022-223356corr1"},{"issue":"2 Suppl","key":"7854_CR3","doi-asserted-by":"publisher","first-page":"S126","DOI":"10.1002\/art.23364","volume":"58","author":"YP Goekoop-Ruiterman","year":"2008","unstructured":"Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF et al (2008) Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 58(2 Suppl):S126\u2013S135. https:\/\/doi.org\/10.1002\/art.23364","journal-title":"Arthritis Rheum"},{"issue":"Suppl 2","key":"7854_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/ar4685","volume":"16","author":"M Cutolo","year":"2014","unstructured":"Cutolo M, Spies CM, Buttgereit F, Paolino S, Pizzorni C (2014) The supplementary therapeutic DMARD role of low-dose glucocorticoids in rheumatoid arthritis. Arthritis Res Ther 16(Suppl 2):S1. https:\/\/doi.org\/10.1186\/ar4685","journal-title":"Arthritis Res Ther"},{"issue":"9074","key":"7854_CR5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0140-6736(97)01300-7","volume":"350","author":"M Boers","year":"1997","unstructured":"Boers M, Verhoeven AC, Markusse HM et al (1997) Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis [published correction appears in Lancet 1998 Jan 17;351(9097):220]. Lancet 350(9074):309\u2013318. https:\/\/doi.org\/10.1016\/S0140-6736(97)01300-7","journal-title":"Lancet"},{"issue":"7","key":"7854_CR6","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/art.41752","volume":"73","author":"L Fraenkel","year":"2021","unstructured":"Fraenkel L, Bathon JM, England BR et al (2021) 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol 73(7):1108\u20131123. https:\/\/doi.org\/10.1002\/art.41752","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"7854_CR7","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1136\/annrheumdis-2021-220112","volume":"80","author":"W Xie","year":"2021","unstructured":"Xie W, Huang H, Li G et al (2021) Dynamical trajectory of glucocorticoids tapering and discontinuation in patients with rheumatoid arthritis commencing glucocorticoids with csDMARDs: a real-world data from 2009 to 2020. Ann Rheum Dis 80(8):997\u20131003. https:\/\/doi.org\/10.1136\/annrheumdis-2021-220112","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"7854_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003366","volume":"9","author":"A Delteil","year":"2023","unstructured":"Delteil A, Lambert C, Pereira B et al (2023) Glucocorticoid trajectories over 2 years in patients with rheumatoid arthritis in a real-life setting. RMD Open 9(4):e003366. https:\/\/doi.org\/10.1136\/rmdopen-2023-003366","journal-title":"RMD Open"},{"issue":"1","key":"7854_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/acr2.11334","volume":"4","author":"KM Andersen","year":"2022","unstructured":"Andersen KM, Schieir O, Valois MF et al (2022) A bridge too far? Real-world practice patterns of early glucocorticoid use in the Canadian Early Arthritis Cohort. ACR Open Rheumatol 4(1):57\u201364. https:\/\/doi.org\/10.1002\/acr2.11334","journal-title":"ACR Open Rheumatol"},{"issue":"4","key":"7854_CR10","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/acr.23611","volume":"71","author":"JC Wilson","year":"2019","unstructured":"Wilson JC, Sarsour K, Gale S, Peth\u00f6-Schramm A, Jick SS, Meier CR (2019) Incidence and risk of glucocorticoid-associated adverse effects in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) 71(4):498\u2013511. https:\/\/doi.org\/10.1002\/acr.23611","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"7854_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0166468","volume":"11","author":"RJ Black","year":"2016","unstructured":"Black RJ, Hill CL, Lester S, Dixon WG (2016) The association between systemic glucocorticoid use and the risk of cataract and glaucoma in patients with rheumatoid arthritis: a systematic review and meta-analysis. PLoS One 11(11):e0166468. https:\/\/doi.org\/10.1371\/journal.pone.0166468","journal-title":"PLoS One"},{"issue":"1","key":"7854_CR12","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1136\/annrheumdis-2011-201162","volume":"72","author":"PH de Jong","year":"2013","unstructured":"de Jong PH, Hazes JM, Barendregt PJ et al (2013) Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial. Ann Rheum Dis 72(1):72\u201378. https:\/\/doi.org\/10.1136\/annrheumdis-2011-201162","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"7854_CR13","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1007\/s00296-024-05713-2","volume":"44","author":"W Xie","year":"2024","unstructured":"Xie W, Huang H, Geng Y, Fan Y, Zhang Z (2024) Current practice, trends and attitudes of rheumatologists towards glucocorticoids use for rheumatoid arthritis (GURANTEE): a national cross-sectional survey across China. Rheumatol Int 44(11):2473\u20132482. https:\/\/doi.org\/10.1007\/s00296-024-05713-2","journal-title":"Rheumatol Int"},{"issue":"1","key":"7854_CR14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s00393-015-0019-5","volume":"75","author":"K Albrecht","year":"2016","unstructured":"Albrecht K, Callhoff J, Edelmann E, Schett G, Schneider M, Zink A (2016) Klinische Remission bei rheumatoider Arthritis. Daten aus der Fr\u00fcharthritiskohortenstudie CAPEA [Clinical remission in rheumatoid arthritis. Data from the early arthritis cohort study CAPEA]. Z Rheumatol 75(1):90\u201396. https:\/\/doi.org\/10.1007\/s00393-015-0019-5","journal-title":"Z Rheumatol"},{"issue":"1","key":"7854_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1461-3","volume":"19","author":"RJ Black","year":"2017","unstructured":"Black RJ, Lester S, Buchbinder R et al (2017) Factors associated with oral glucocorticoid use in patients with rheumatoid arthritis: a drug use study from a prospective national biologics registry. Arthritis Res Ther 19(1):253. https:\/\/doi.org\/10.1186\/s13075-017-1461-3","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"7854_CR16","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.semarthrit.2019.09.002","volume":"50","author":"BI Wallace","year":"2020","unstructured":"Wallace BI, Lin P, Kamdar N et al (2020) Patterns of glucocorticoid prescribing and provider-level variation in a commercially insured incident rheumatoid arthritis population: a retrospective cohort study. Semin Arthritis Rheum 50(2):228\u2013236. https:\/\/doi.org\/10.1016\/j.semarthrit.2019.09.002","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"7854_CR17","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1002\/acr.24382","volume":"73","author":"MD George","year":"2021","unstructured":"George MD, Baker JF, Wallace B et al (2021) Variability in glucocorticoid prescribing for rheumatoid arthritis and the influence of provider preference on long-term use of glucocorticoids. Arthritis Care Res (Hoboken) 73(11):1597\u20131605. https:\/\/doi.org\/10.1002\/acr.24382","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"7854_CR18","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1517\/14740338.2016.1140743","volume":"15","author":"M Oray","year":"2016","unstructured":"Oray M, Abu Samra K, Ebrahimiadib N, Meese H, Foster CS (2016) Long-term side effects of glucocorticoids. Expert Opin Drug Saf 15(4):457\u2013465. https:\/\/doi.org\/10.1517\/14740338.2016.1140743","journal-title":"Expert Opin Drug Saf"},{"issue":"7","key":"7854_CR19","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1136\/ard.2008.092163","volume":"68","author":"D Huscher","year":"2009","unstructured":"Huscher D, Thiele K, Gromnica-Ihle E et al (2009) Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis 68(7):1119\u20131124. https:\/\/doi.org\/10.1136\/ard.2008.092163","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"7854_CR20","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1093\/rheumatology\/39.12.1383","volume":"39","author":"TP van Staa","year":"2000","unstructured":"van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C (2000) Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology Oxford 39(12):1383\u20131389. https:\/\/doi.org\/10.1093\/rheumatology\/39.12.1383","journal-title":"Rheumatology Oxford"},{"issue":"9","key":"7854_CR21","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1136\/annrheumdis-2013-203341","volume":"73","author":"A Zink","year":"2014","unstructured":"Zink A, Manger B, Kaufmann J et al (2014) Evaluation of the RABBIT risk score for serious infections. Ann Rheum Dis 73(9):1673\u20131676. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203341","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"7854_CR22","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.1002\/art.21421","volume":"52","author":"S Wassenberg","year":"2005","unstructured":"Wassenberg S, Rau R, Steinfeld P, Zeidler H (2005) Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum 52(11):3371\u20133380. https:\/\/doi.org\/10.1002\/art.21421","journal-title":"Arthritis Rheum"},{"issue":"4","key":"7854_CR23","doi-asserted-by":"publisher","first-page":"299","DOI":"10.7326\/0003-4819-157-4-201208210-00019","volume":"157","author":"AD Protogerou","year":"2012","unstructured":"Protogerou AD, Zampeli E, Sfikakis PP (2012) Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis. Ann Intern Med 157(4):299\u2013300. https:\/\/doi.org\/10.7326\/0003-4819-157-4-201208210-00019","journal-title":"Ann Intern Med"},{"issue":"10","key":"7854_CR24","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1002\/art.42245","volume":"74","author":"D Krause","year":"2022","unstructured":"Krause D, Mai A, Klaassen-Mielke R et al (2022) The efficacy of short-term bridging strategies with high- and low-dose prednisolone on radiographic and clinical outcomes in active early rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial. Arthritis Rheumatol 74(10):1628\u20131637. https:\/\/doi.org\/10.1002\/art.42245","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"7854_CR25","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1002\/art.21405","volume":"52","author":"YP Goekoop-Ruiterman","year":"2005","unstructured":"Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF et al (2005) Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 52(11):3381\u20133390. https:\/\/doi.org\/10.1002\/art.21405","journal-title":"Arthritis Rheum"},{"issue":"12","key":"7854_CR26","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1093\/rheumatology\/kez213","volume":"58","author":"V Stouten","year":"2019","unstructured":"Stouten V, Westhovens R, Pazmino S et al (2019) Effectiveness of different combinations of DMARDs and glucocorticoid bridging in early rheumatoid arthritis: two-year results of CareRA. Rheumatology (Oxford) 58(12):2284\u20132294. https:\/\/doi.org\/10.1093\/rheumatology\/kez213","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"7854_CR27","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/BF02231779","volume":"12","author":"MJ van der Veen","year":"1993","unstructured":"van der Veen MJ, Bijlsma JW (1993) The effect of methylprednisolone pulse therapy on methotrexate treatment of rheumatoid arthritis. Clin Rheumatol 12(4):500\u2013505. https:\/\/doi.org\/10.1007\/BF02231779","journal-title":"Clin Rheumatol"},{"issue":"1","key":"7854_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1136\/annrheumdis-2013-203440","volume":"73","author":"JL Nam","year":"2014","unstructured":"Nam JL, Villeneuve E, Hensor EMA et al (2014) Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study). Ann Rheum Dis 73(1):75\u201385. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203440","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"7854_CR29","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1007\/s10067-016-3397-4","volume":"35","author":"M Hajialilo","year":"2016","unstructured":"Hajialilo M, Ghorbanihaghjo A, Valaee L et al (2016) A double-blind randomized comparative study of triamcinolone hexacetonide and dexamethasone intra-articular injection for the treatment of knee joint arthritis in rheumatoid arthritis. Clin Rheumatol 35(12):2887\u20132891. https:\/\/doi.org\/10.1007\/s10067-016-3397-4","journal-title":"Clin Rheumatol"},{"issue":"4","key":"7854_CR30","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/1756-185X.12278","volume":"17","author":"V Sadra","year":"2014","unstructured":"Sadra V, Khabbazi A, Kolahi S, Hajialiloo M, Ghojazadeh M (2014) Randomized double-blind study of the effect of dexamethasone and methylprednisolone pulse in the control of rheumatoid arthritis flare-up: a preliminary study. Int J Rheum Dis 17(4):389\u2013393. https:\/\/doi.org\/10.1111\/1756-185X.12278","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"7854_CR31","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1002\/art.21796","volume":"54","author":"ML Hetland","year":"2006","unstructured":"Hetland ML, Stengaard-Pedersen K, Junker P et al (2006) <article-title update=\"added\">Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator\u2010initiated, multicenter, randomized, double\u2010blind, parallel\u2010group, placebo\u2010controlled study. Arthritis Rheum 54(5):1401\u20131409. https:\/\/doi.org\/10.1002\/art.21796","journal-title":"Arthritis Rheum"},{"key":"7854_CR32","doi-asserted-by":"publisher","unstructured":"Hetland ML, \u00d8stergaard M, Ejbjerg B, et al. Short- and long-term efficacy of intra-articular injections with betamethasone as part of a treat-to-target strategy in early rheumatoid arthritis: impact of joint area, repeated injections, MRI findings, anti-CCP, IgM-RF and CRP [published correction appears in Ann Rheum Dis. 2012 Nov;71(11):1918].\u00a0Ann Rheum Dis. 2012;71(6):851\u2013856. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200632","DOI":"10.1136\/annrheumdis-2011-200632"},{"issue":"10","key":"7854_CR33","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1002\/art.22943","volume":"56","author":"D Aletaha","year":"2007","unstructured":"Aletaha D, Funovits J, Keystone EC, Smolen JS (2007) Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patients. Arthritis Rheum 56(10):3226\u20133235. https:\/\/doi.org\/10.1002\/art.22943","journal-title":"Arthritis Rheum"},{"key":"7854_CR34","doi-asserted-by":"publisher","unstructured":"Burgers LE, Raza K, van der Helm- Mil AH (2019) Window of opportunity in rheumatoid arthritis - definitions and supporting evidence: from old to new perspectives. RMD Open. Window of opportunity in rheumatoid arthritis - definitions and supporting evidence: from old to new perspectives. RMD Open 5(1):e000870. https:\/\/doi.org\/10.1136\/rmdopen-2018-000870","DOI":"10.1136\/rmdopen-2018-000870"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07854-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07854-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07854-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T09:02:36Z","timestamp":1769763756000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07854-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["7854"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07854-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,16]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This single-center retrospective non-inferiority cohort study was approved by the Ethics Committee of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine (KY2024-463) and registered at the Chinese Clinical Trial Registry (ChiCTR2400093187), and carried out under the Declaration of Helsinki. Informed consent was waived due to the retrospective nature of data collection from existing electronic health records. All patient records underwent personal identifiers\u2019 removal before analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}